IBM increased its presence in the device world in a major way, announcing a collaboration around famous supercomputer Watson with Medtronic, Johnson & Johnson and Apple.
Medtronic has officially joined the European leadless pacemaker market thanks to the CE-mark approval of its Micra Transcatheter Pacing System. It is one-tenth the size of conventional pacemakers, making it the world's smallest device in the overall category.
Ortho Kinematics will use the $9.6 million it has raised to support its mission to make its Vertebral Motion Analysis test the standard of care to assess spinal motion and instability. The financing is the lion's share of a total of $10.7 million the company expects to raise.
Medtronic announced the U.S. launch of its HawkOne directional atherectomy system, for surgical treatment of peripheral artery disease, or blocked and calcified arteries in the arms or legs. The device was obtained via Medtronic's $50 billion acquisition of Covidien.
A strategic device company, a former Medtronic president and an award-winning Stanford doctor are among the financiers of Silicon Valley's EBR Systems' attempt to commercialize the first leadless pacemaker implanted in the heart's left ventricle. Along with VCs like Split Rock Partners and SV Life Sciences, the group contributed $20 million toward the groundbreaking effort.
Spinal specialist Benvenue Medical is taking on Medtronic. The smaller company boasted of clinical trial results showing that its FDA-cleared Kiva VCF System to treat vertebral compression fractures performs as well as or better than the industry bigwig's KyphX System.
Medtronic agreed to pay $4.4 million to settle a Department of Justice lawsuit claiming that the company mislabeled imported devices as made in the USA so that it could sell them to the U.S. military.
Medtronic snatched up artificial pancreas technology from Israel-based DreaMed Diabetes for its insulin pumps, the company's latest deal as it looks to diversify its diabetes offerings and cash in on a growing market.
Medtronic has agreed to pay the U.S. government $4.41 million to settle allegations that it sold some cardiac- and spinal-related devices illegally manufactured in China and Malaysia for most of the past 8 years. Three whistleblowers are to receive shares of the settlement.
Med tech company executives often talk about the need to provide not just products but "solutions" to problems like meeting Affordable Care Act metrics at hospitals and lowering the cost of patient care. Now, Medtronic is expanding its push into healthcare services to a new front with the acquisition of the Netherlands' diabetes and research clinic Diabeter.